AMY CAMPBELL: Open Payments
NPI 1194081190 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,171 in 153 payments from 39 companies in 2025. Trend: 2023 $2,105 · 2024 $2,643 · 2025 $3,171
Food & beverage: $3,091Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $305 |
| AstraZeneca Pharmaceuticals LP | 11 | $264 |
| Novartis Pharmaceuticals Corporation | 13 | $246 |
| PFIZER INC. | 10 | $210 |
| Incyte Corporation | 9 | $206 |
| Daiichi Sankyo Inc. | 8 | $197 |
| Celgene Corporation | 16 | $187 |
| E.R. Squibb & Sons, L.L.C. | 8 | $136 |
| ARRAY BIOPHARMA INC | 6 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $109 |
Products named: Enhertu, REBLOZYL, JAKAFI, TAGRISSO, ERLEADA, Fabhalta, MONOFERRIC, LIBTAYO.
Industry payments across TN — which companies pay providers there.
